1rwn image
Deposition Date 2003-12-16
Release Date 2004-12-28
Last Version Date 2024-10-30
Entry Detail
PDB ID:
1RWN
Keywords:
Title:
Crystal structure of human caspase-1 in complex with 3-{2-ethyl-6-[4-(quinoxalin-2-ylamino)-benzoylamino]-hexanoylamino}-4-oxo-butyric acid
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.23
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 43 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Interleukin-1 beta convertase
Gene (Uniprot):CASP1
Chain IDs:A
Chain Length:178
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Interleukin-1 beta convertase
Gene (Uniprot):CASP1
Chain IDs:B
Chain Length:88
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structural analysis of caspase-1 inhibitors derived from Tethering.
Acta Crystallogr.,Sect.F 61 451 458 (2005)
PMID: 16511067 DOI: 10.1107/S1744309105010109

Abstact

Caspase-1 is a key endopeptidase responsible for the post-translational processing of the IL-1beta and IL-18 cytokines and small-molecule inhibitors that modulate the activity of this enzyme are predicted to be important therapeutic treatments for many inflammatory diseases. A fragment-assembly approach, accompanied by structural analysis, was employed to generate caspase-1 inhibitors. With the aid of Tethering with extenders (small molecules that bind to the active-site cysteine and contain a free thiol), two novel fragments that bound to the active site and made a disulfide bond with the extender were identified by mass spectrometry. Direct linking of each fragment to the extender generated submicromolar reversible inhibitors that significantly reduced secretion of IL-1beta but not IL-6 from human peripheral blood mononuclear cells. Thus, Tethering with extenders facilitated rapid identification and synthesis of caspase-1 inhibitors with cell-based activity and subsequent structural analyses provided insights into the enzyme's ability to accommodate different inhibitor-binding modes in the active site.

Legend

Protein

Chemical

Disease

Primary Citation of related structures